CAS No.: | 95233-18-4 |
---|---|
Formula: | C22h19clo3 |
Type: | Pharmaceutical Intermediates |
Appearance: | Powder |
Quality: | Refined |
Colour: | Yellow |
Leveranciers met geverifieerde zakelijke licenties
Productnaam | Atovaquone |
Uiterlijk | Geel poeder |
CAS-NR. | 95233-18-4 |
MF | C22H19ClO3 |
MW | 366.841 |
Analyse | 99%+ |
Nee | Engelse naam van het product. | CAS-nr. |
Antivirale middelen | ||
2 | Natrium (API) | 107910-75-8 |
3 | Valganciclovir hydrochloride (API) | 175865-59-5 |
N-2-acetylguanine | 19962-37-9 | |
CBZ-valganciclovir | 194154-40-0 | |
Mono-o-acetaat | 88110-89-8 | |
Triacetylganciclovir | 86357-14-4 | |
- | 89281-73-2 | |
- | 86357-13-3 | |
4 | Valaciclovir hydrochloride (API) | 124832-27-5 |
5 | Monohydraat (API) | 209216-23-9 |
Antivirale middelen | ||
- | 2346620-55-9 | |
4-amino1-((3aR,4R,6R,6AR)-6-(hydroxymethyl)-2,2-dimethyltetrahydrofuro[3,4-d][1,3]dioxol-4-yl)pyrimidine-2(1H)-een sulfaat | 1955522-00-5 | |
7 | N(4)-hydroxycytidine EIDD-1931 | 3258-02-4 |
8 | Nirmatrelvir Nirmatrelvir CAS#2628280-40-8 | 2628280-40-8 |
10 | phos-faat (API) | 204255-11-8 |
11 | Rem-desivir (API) | 1809249-37-3 |
Antidiabetisch | ||
12 | Sitagliptinfosfaat (API) | 654671-78-0 |
13 | Sitagliptin-fos-faat-monohydraat (API) | 654671-77-9 |
Sitagliptin | 486460-32-6 | |
3-(Trifluoromethyl)-5,6,7,8-tetrahydro-[1,2,4]tria zolo[4,3-a]pyrazine-hydrochloride |
762240-92-6 | |
BOC-(R)-3-Amino-4-(2,4,5-trifluorofenyl)butanoic acid | 486460-00-8 | |
2,4,5-Trifluorofenylazijnzuur | 209995-38-0 | |
14 | Empagliflozin (API) | 864070-44-0 |
- | 915095-99-7 | |
- | 1279691-36-9 | |
15 | Imegaline (hydrochloride) (API) | 775351-61-6 |
16 | Imegaline (API) | 775351-65-0 |
17 | Vildagliptin (API) | 274901-16-5 |
18 | Repaglinide (API) | 135062-02-1 |
3-ethoxy-4-ethoxycarbonylfenylazijnzuur | 99469-99-5 | |
(S)-3-METHYL-1-(2-PIPERIDINOFENYL)BUTYLMIN, N-ACETYL-GLUTAMAAT ZOUT | 219921-94-5 | |
19 | Trelagliptin-succinaat (API) | 1029877-94-8 |
20 | Alogliptin-benzoaat (API) | 850649-62-6 |
21 | Linagliptin (API) | 668270-12-0 |
22 | Canagiliflozin (API) | 928672-86-0 |
23 | Dapagliflozin (API) | 960404-48-2 |
24 | Teneligliptin -hydrobromidehydraat (API) | 1572583-29-9 |
Antikanker | ||
25 | Imatinib mesylaat (API) | 220127-57-1 |
Imatinib | 152459-95-5 | |
N-desmethyl-imatinib | 404844-02-6 | |
N-(5-Amino-2-methylfenyl)-4-(3-pyridyll)-2- pyrimid-anine |
152460-10-1 | |
4-[(4-methylpiperazine-1-yl)methyl]benzoëzuur dihydrochloride |
106261-49-8 | |
4-[(4-methyl-1-piperazinyl)methyl]benzoylchloride dihydrochloride | 106261-64-7 | |
26 | Dasatinib-monohydraat (API) | 863127-77-9 |
Antikanker | ||
27 | Olabarib (API) | 763113-22-0 |
2-fluoro-5-((4-oxo-3,4-dihydroftalazine-1-yl) methyl)benzoëzuur | 763114-26-7 | |
28 | Niraparib Tosylate-monohydraat (API) | 1613220-15-7 |
MK-4827,Niraparib | 1038915-60-4 | |
N-tert-butyl-1H-indazol-7-carboxamide | 1476776-76-7 | |
(S) -3- (4-broomfenyl) Piperidine-1-carboxylaat | 1476776-55-2 | |
(S)-3-(4-Bromophenyl)piperidine | 1335523-82-4 | |
(S)-tert-butyl 3-(4-aMinophenyl)piperidine-1-carboxylaat | 1171197-20-8 | |
3-formyl-2-nitrobenzoëzuur methylester | 138229-59-1 | |
Antikanker | ||
29 | - (API) | - |
30 | Erlotinib-hydrochloride (API) | 183319-69-9 |
3-aminophenylacetyleen HCL | 207726-02-6 | |
2-Amino-4,5-bis(2-methoxyethoxy)benzoëzuur-ethylester hydrochloride |
183322-17-0 | |
31 | Ibrutinib (API) | 936563-96-1 |
- | 1022150-12-4 | |
3- (4-fenoxyfenyl) -1h-Pyrazolo[3, 4-D]Pyrimidine-4-amine |
330786-24-8 | |
Antikanker | ||
32 | Sorafenib-tosylaat (API) | 475207-59-1 |
Antikanker | ||
33 | Tofacitinib citraat (API) | 540737-29-9 |
4-Chloro-7H-pyrrolo[2,3-d]pyrimidine | 3680-69-1 | |
- | 3680-71-5 | |
Prostaglandine antagonisten/antagonist | ||
34 | Mirabegron (API) | 223673-61-8 |
35 | Silodosine (API) | 160970-54-7 |
2-[2-(2,2,2-Trifluoroethoxy)-fenoxy]-ethyl methanesulfonaat |
160969-03-9 | |
5-[(2R)-2-Aminopropyl]-1-[3-(benzoyloxy)propyl]-2, 3-dihydroxybutanedioaat-1H-indole-7-carbonitril (2R,3R)-2,3-dihydroxybutanedioaat |
239463-85-5 | |
Schoonheid en witten zijn bestand tegen oxidatie | ||
36 | Ectoine (API) | 96702-03-3 |
37 | N-(1-Oxo-10-undecen-1-yl)-L-fenylalanine Α-MSH |
175357-18-3 |
Cardiovasculair | ||
38 | Ticagrelor -formulier | 274693-27-5 |
4,6-dichloor2-propylthiopyrimidine-5-amine | 145783-15-9 | |
2-((3aR,4S,6R,6AS)-6-amino-2,2-dimethyltetrahydro -3AH-cyclopenta[d][1,3]dioxol-4-yloxy)ethanol L-tatarisch zuur |
376608-65-0 | |
- | 376608-71-8 | |
(1R,2S)-2-(3,4-difluorophenyl)cyclopropanamine hydrochloride | 1156491-10-9 | |
andere | ||
39 | Baricitinib (API) | 1187594-09-7 |
40 | Beta-nicotinamide mononucleotide | 1094-61-7 |
42 | Natriumfusidaat | 751-94-0 |
43 | Elagolix-natrium | 832720-36-2 |
1-(2-Flouro-6-(trifloromethyl)benzyl)-6-methylpyrimidine-2,4-(1H,3H)-dion | 830346-47-9 | |
44 | Enoxaparine Sodium | 679809-58-6 |
R&D-producten | ||
2-methyl-5-nitroimidazol | 88054-22-2 | |
1 | Upadacitinib | 1310726-60-3 |
2 | Regorafenib | 755037-03-7 |
3 | Abemaciclib | 1231929-97-7 |
4 | Darolutamide | 1297538-32-9 |
5 | Octanoïnezuur;6,8 bis[(fenylmethyl)thio]- | 95809-78-2 |
6 | Rebamipide | 90098-04-7 |
7 | Mavacamten | 1642288-47-8 |
8 | Relugoix | 737789-87-6 |
10 | Fingolimod-hydrochloride | 162359-56-0 |
1- (2-Iodoethyl) -4-octylbenzeen | 162358-07-8 | |
12 | Azilsartan | 147403-03-0 |
13 | Cabozantinib Malate | 1140909-48-3 |
15 | Lenvatinib mesylaat | 857890-39-2 |
Leveranciers met geverifieerde zakelijke licenties